AtriCure Cash on Hand 2006-2018 | ATRC

AtriCure cash on hand from 2006 to 2018. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
AtriCure Annual Cash on Hand
(Millions of US $)
2018 $124
2017 $34
2016 $44
2015 $35
2014 $60
2013 $26
2012 $12
2011 $14
2010 $13
2009 $16
2008 $11
2007 $20
2006 $19
2005 $34
AtriCure Quarterly Cash on Hand
(Millions of US $)
Q4 2018 $124
Q3 2018 $40
Q2 2018 $37
Q1 2018 $36
Q4 2017 $34
Q3 2017 $34
Q2 2017 $35
Q1 2017 $34
Q4 2016 $44
Q3 2016 $41
Q2 2016 $42
Q1 2016 $23
Q4 2015 $35
Q3 2015 $48
Q2 2015 $54
Q1 2015 $56
Q4 2014 $60
Q3 2014 $59
Q2 2014 $63
Q1 2014 $79
Q4 2013 $26
Q3 2013 $30
Q2 2013 $35
Q1 2013 $36
Q4 2012 $12
Q3 2012 $13
Q2 2012 $13
Q1 2012 $15
Q4 2011 $14
Q3 2011 $15
Q2 2011 $16
Q1 2011 $16
Q4 2010 $13
Q3 2010 $11
Q2 2010 $12
Q1 2010 $12
Q4 2009 $16
Q3 2009 $15
Q2 2009 $16
Q1 2009 $9
Q4 2008 $11
Q3 2008 $12
Q2 2008 $12
Q1 2008 $15
Q4 2007 $20
Q3 2007 $21
Q2 2007 $29
Q1 2007 $16
Q4 2006 $19
Q3 2006 $20
Q2 2006 $25
Q1 2006 $28
Q4 2005 $34
Q3 2005 $38
Q2 2005 $1
Q1 2005 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.052B $0.202B
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $128.012B 24.96
Medtronic (MDT) Ireland $113.636B 16.61
Stryker (SYK) United States $67.248B 24.66
Boston Scientific (BSX) United States $48.542B 23.59
Baxter (BAX) United States $38.022B 24.39
Zimmer Biomet Holdings (ZBH) United States $24.486B 15.67
Smith & Nephew SNATS (SNN) United Kingdom $16.790B 0.00
Canopy Growth (CGC) Canada $14.340B 0.00
ResMed (RMD) United States $13.953B 26.46
Aurora Cannabis (ACB) Canada $9.078B 64.00
Bio-Rad Laboratories (BIO) United States $8.696B 49.88
Perrigo (PRGO) Ireland $6.775B 10.98
Hill-Rom Holdings (HRC) United States $6.356B 19.66
Insulet (PODD) United States $4.935B 1654.40
GW Pharmaceuticals (GWPH) United Kingdom $4.697B 0.00
ICU Medical (ICUI) United States $4.641B 28.74
Haemonetics (HAE) United States $4.169B 36.99
Hutchison China MediTech (HCM) China $4.067B 0.00
Agios Pharmaceuticals (AGIO) United States $3.290B 0.00
Neogen (NEOG) United States $2.877B 46.77
NuVasive (NUVA) United States $2.794B 24.27
Quidel (QDEL) United States $2.380B 21.30
National Vision Holdings (EYE) United States $2.239B 44.05
Aphria (APHA) $1.960B 0.00
HEXO (HEXO) $1.401B 0.00
Phibro Animal Health (PAHC) United States $1.345B 19.33
VAREX IMAGING (VREX) United States $1.192B 23.34
Cardiovascular Systems (CSII) United States $1.182B 848.25
Omeros (OMER) United States $0.928B 0.00
Lantheus Holdings (LNTH) United States $0.921B 24.90
PetIQ (PETQ) United States $0.851B 24.36
MacroGenics (MGNX) United States $0.798B 0.00
Cerus (CERS) United States $0.794B 0.00
NanoString Technologies (NSTG) United States $0.741B 0.00
TG Therapeutics (TGTX) United States $0.716B 0.00
Evolus (EOLS) United States $0.659B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.656B 22.33
OraSure Technologies (OSUR) United States $0.593B 25.81
Surmodics (SRDX) United States $0.543B 79.00
LeMaitre Vascular (LMAT) United States $0.532B 25.29
Meridian Bioscience (VIVO) United States $0.531B 15.81
Quanterix (QTRX) United States $0.478B 0.00
Insys Therapeutics (INSY) United States $0.320B 0.00
Utah Medical Products (UTMD) United States $0.316B 20.57
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.309B 0.00
BioLife Solutions (BLFS) United States $0.308B 126.92
Vapotherm (VAPO) United States $0.289B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Owens & Minor (OMI) United States $0.228B 3.12
Cytosorbents (CTSO) United States $0.224B 0.00
Zynex (ZYXI) United States $0.171B 18.28
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.125B 0.00
Chembio Diagnostics (CEMI) United States $0.124B 0.00
Fonar (FONR) United States $0.123B 6.60
Surface Oncology (SURF) United States $0.111B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
United-Guardian (UG) United States $0.086B 19.81
Female Health (VERU) United States $0.081B 0.00
CAS Medical Systems (CASM) United States $0.072B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
Neurotrope (NTRP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 20.34
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.033B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.021B 0.00
Myomo (MYO) United States $0.020B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.03